1. Home
  2. VACHU
  3. VACHU News

Latest VOYAGER ACQUISITION CORP UNIT 1 COM & 1/2 WT EXP (VACHU) News on June 2, 2025

VACHU

GlobeNewswire

4 days ago

VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
VACHU

GlobeNewswire

13 days ago

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer

VACHU

MT Newswires

a month ago

OmniAb, Veraxa Biotech Partner on Solid Tumor Drug Discovery Program

VACHU

GlobeNewswire

a month ago

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

Veraxa to go public in $1.6bn SPAC deal with Voyager
VACHU

Pharmaceutical Technology

a month ago

Veraxa to go public in $1.6bn SPAC deal with Voyager

VACHU

MT Newswires

a month ago

Voyager Acquisition, VERAXA Biotech to Merge, Creating $1.64 Billion Public Cancer Therapy Company

VACHU

GlobeNewswire

a month ago

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies

VACHU

GlobeNewswire

8 months ago

Voyager Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about September 30, 2024

VACHU

GlobeNewswire

10 months ago

Voyager Acquisition Corp. Announces Closing of $253,000,000 Initial Public Offering

VACHU

GlobeNewswire

10 months ago

Voyager Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering

Share on Social Networks: